Esperion Therapeutis.Inc. buy Wolf_of_WS
Summary
This prediction ended on 15.04.23 with a price of €1.15. With a performance of -9.05%, the BUY prediction for Esperion Therapeutis.Inc. by Wolf_of_WS closed slightly in the red. Wolf_of_WS has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Esperion Therapeutis.Inc. | 9.218% | 9.218% | 86.289% |
iShares Core DAX® | 1.776% | 3.175% | 14.882% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% |
According to Wolf_of_WS what are the pros and cons of Esperion Therapeutis.Inc. for the foreseeable future?
Pros
Cons
Comments by Wolf_of_WS for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
In the thread Trading Esperion Therapeutis.Inc.
Stopped prediction by Wolf_of_WS for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
21.09.23
21.09.24
01.10.23
Esperion Therapeutis.Inc.
23.08.23
23.08.24
30.08.23
Esperion Therapeutis.Inc.
10.05.23
10.05.24
15.05.23